A NOVEL TARGETED DRUG DELIVERY SYSTEM FOR RIVASTIGMINE IN LIPOSOMES AND NANOPARTICLES FORM FOR TH E TREATMENT OF ALZHEIMER'S DISEASE

摘要

The invention relates to a novel drug delivery system for rivastingmine in liposomes and nanoparticles form for the treatment of/ Alzheimer's disease. It further disclosed formulation development and evaluation of new drug carrier system, through intranasal or oral administration of rivastigmine loaded liposome's and nanoparticles to target brain for the treatment of Alzheimer's disease, which could have potentials for other drugs, therapeutic actions to target other organs as well.